Entresto 49 MG-51 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FA3R3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,256
Award facts
- Contract value 100% obligated
- $11,256.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,256.02 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (60 count) with a completion date of January 27, 2026. This firm fixed-price, non-set-aside delivery order was issued on January 26, 2026, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The order represents a task against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering a diverse range of pharmaceutical products and medical supplies across multiple therapeutic domains. This particular delivery order for Entresto—a heart failure medication—exemplifies the company's role in supporting the Department of Defense's medical supply chain and reflects its continued competitiveness in open contracting for essential pharmaceutical commodities required by military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FA3R3?
SPE2DR26FA3R3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FA3R3 worth?
The government has obligated $11,256 on SPE2DR26FA3R3.
Is contract SPE2DR26FA3R3 an order under another contract?
Yes. SPE2DR26FA3R3 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA3R3 competed?
The extent of competition for SPE2DR26FA3R3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award